Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis.

Lionaki S, Blyth ER, Hogan SL, Hu Y, Senior BA, Jennette CE, Nachman PH, Jennette JC, Falk RJ.

Arthritis Rheum. 2012 Oct;64(10):3452-62. doi: 10.1002/art.34562.

2.

High basal activity of the PTPN22 gain-of-function variant blunts leukocyte responsiveness negatively affecting IL-10 production in ANCA vasculitis.

Cao Y, Yang J, Colby K, Hogan SL, Hu Y, Jennette CE, Berg EA, Zhang Y, Jennette JC, Falk RJ, Preston GA.

PLoS One. 2012;7(8):e42783. doi: 10.1371/journal.pone.0042783. Epub 2012 Aug 3.

3.

Glucocorticoids and relapse and infection rates in anti-neutrophil cytoplasmic antibody disease.

McGregor JG, Hogan SL, Hu Y, Jennette CE, Falk RJ, Nachman PH.

Clin J Am Soc Nephrol. 2012 Feb;7(2):240-7. doi: 10.2215/CJN.05610611. Epub 2011 Dec 1.

4.

Venous thromboembolism in patients with membranous nephropathy.

Lionaki S, Derebail VK, Hogan SL, Barbour S, Lee T, Hladunewich M, Greenwald A, Hu Y, Jennette CE, Jennette JC, Falk RJ, Cattran DC, Nachman PH, Reich HN.

Clin J Am Soc Nephrol. 2012 Jan;7(1):43-51. doi: 10.2215/CJN.04250511. Epub 2011 Nov 10.

5.

DRB1*15 allele is a risk factor for PR3-ANCA disease in African Americans.

Cao Y, Schmitz JL, Yang J, Hogan SL, Bunch D, Hu Y, Jennette CE, Berg EA, Arnett FC Jr, Jennette JC, Falk RJ, Preston GA.

J Am Soc Nephrol. 2011 Jun;22(6):1161-7. doi: 10.1681/ASN.2010101058. Epub 2011 May 26.

6.

Discrepancy between Medical Evidence Form 2728 and renal biopsy for glomerular diseases.

Layton JB, Hogan SL, Jennette CE, Kenderes B, Krisher J, Jennette JC, McClellan WM.

Clin J Am Soc Nephrol. 2010 Nov;5(11):2046-52. doi: 10.2215/CJN.03550410. Epub 2010 Aug 5.

7.

Community perspectives on kidney disease and health promotion from at-risk populations in rural North Carolina, USA.

Jennette CE, Vupputuri S, Hogan SL, Shoham DA, Falk RJ, Harward DH.

Rural Remote Health. 2010 Apr-Jun;10(2):1388. Epub 2010 May 17.

8.

The Kidney Education Outreach Program's community-based screenings: participants' demographics and screening results.

Harward DH, Bomback AS, Jennette CE, Amamoo MA, Falk R.

N C Med J. 2009 Nov-Dec;70(6):507-12.

PMID:
20198833
9.

The clinical course of ANCA small-vessel vasculitis on chronic dialysis.

Lionaki S, Hogan SL, Jennette CE, Hu Y, Hamra JB, Jennette JC, Falk RJ, Nachman PH.

Kidney Int. 2009 Sep;76(6):644-51. doi: 10.1038/ki.2009.218. Epub 2009 Jun 17.

10.

Vasculitis and anti-thyroid medication.

Lionaki S, Hogan SL, Falk RJ, Joy MS, Jennette CE, Nachman PH, Jennette JC.

Nephrol Dial Transplant. 2008 May;23(5):1766-8; author reply 1768. doi: 10.1093/ndt/gfm887. Epub 2007 Dec 21. No abstract available.

11.

Association of silica exposure with anti-neutrophil cytoplasmic autoantibody small-vessel vasculitis: a population-based, case-control study.

Hogan SL, Cooper GS, Savitz DA, Nylander-French LA, Parks CG, Chin H, Jennette CE, Lionaki S, Jennette JC, Falk RJ.

Clin J Am Soc Nephrol. 2007 Mar;2(2):290-9. Epub 2007 Feb 7.

12.

Association between thyroid disease and its treatment with ANCA small-vessel vasculitis: a case-control study.

Lionaki S, Hogan SL, Falk RJ, Joy MS, Chin H, Jennette CE, Jennette JC, Nachman PH.

Nephrol Dial Transplant. 2007 Dec;22(12):3508-15. Epub 2007 Aug 8.

PMID:
17686815
13.

Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants.

Thomas DB, Franceschini N, Hogan SL, Ten Holder S, Jennette CE, Falk RJ, Jennette JC.

Kidney Int. 2006 Mar;69(5):920-6.

14.

Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis.

Hogan SL, Falk RJ, Chin H, Cai J, Jennette CE, Jennette JC, Nachman PH.

Ann Intern Med. 2005 Nov 1;143(9):621-31.

PMID:
16263884

Supplemental Content

Loading ...
Support Center